FDA — authorised 29 October 1992
- Application: NDA020246
- Marketing authorisation holder: PFIZER
- Status: supplemented
FDA authorised Depo Provera on 29 October 1992
Yes. FDA authorised it on 29 October 1992.
PFIZER holds the US marketing authorisation.